# Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial

> **NCT03584022** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 20 (estimated)

## Conditions studied

- Peripheral Neuropathy
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Vasculitic Neuropathy (Disorder)
- Amyloidosis
- Hereditary Neuropathy
- Sarcoid Neuropathy

## Interventions

- **DEVICE:** Biopsy + Nerve Repair
- **PROCEDURE:** Biopsy Only

## Key facts

- **NCT ID:** NCT03584022
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-11-09
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03584022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03584022, "Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03584022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*